http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2241168-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48999ed6d1b0eaa2ba9e3feeb8d11260
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-621
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 1991-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a05c3e44eba63c41c4631a570d444950
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb512f5d4cfb7ad8562a225c34b39692
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dafc5125b2e8d3126118318017f49a19
publicationDate 1991-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2241168-A
titleOfInvention Controlled release product containing salicylate
abstract A pharmaceutical product preferably in the form of a capsule comprises in one case Atenolol and Aspirin. A barrier film coating including a dihydric alcohol is provided around a tablet of Atenolol which in turn is surrounded by Aspirin inside a capsule. Aspirin is preferentially and maximally absorbed in the first hour after ingestion before significant release and absorbtion of Atenolol.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013084089-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015500276-A
priorityDate 1990-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1116438-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0117164-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1276089-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-908282-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2203338-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1546448-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0103991-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2041222-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453336160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87170038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69571058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448513918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479210

Total number of triples: 51.